source
- Trump unveils pricing agreements with midsize biotech firms; Novartis halts CAR-T trial after patient deathsThe White House announced that President Trump has struck new pricing agreements with a group of midsize biotechnology companies, aiming to adjust drug costs. Novartis disclosed that it is pausing…
- K Health plans IPO by 2029 after recent funding roundK Health, a virtual‑care company that uses AI, announced its intention to go public by 2029. CEO Allon Bloch made the comment after a recent fundraising round, signalling the firm is preparing for…